• Shopping Cart
    There are no items in your cart

CLSI H47 A2 : 2ED 2008

Superseded

Superseded

A superseded Standard is one, which is fully replaced by another Standard, which is a new edition of the same Standard.

View Superseded by

ONE-STAGE PROTHROMBIN TIME (PT) TEST AND ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT) TEST

Superseded date

31-03-2023

Superseded by

CLSI H47 ED3:2023

Published date

24-08-2018

Sorry this product is not available in your region.

Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Definitions
5 Practical Considerations for Designing a Comparability
   Monitoring Protocol
   5.1 Causes of Noncomparability of Results
   5.2 Scope of Comparisons
   5.3 Risk Assessment for Noncomparable Results
   5.4 Frequency and Complexity of Comparability Assessment
         Protocols
   5.5 General Approaches to Comparability Testing
   5.6 Triggers for Special Cause Comparability Testing
6 Samples for Comparability Testing
   6.1 Commutability
   6.2 Analyte Concentrations for Testing
   6.3 Storage and Transport
7 Acceptance Criteria for Comparability Testing of Patient Results
   7.1 Evaluation of Comparability Based on Clinical Outcomes
   7.2 Evaluation of Comparability Based on Clinician's
         Questionnaire
   7.3 Evaluation of Comparability Based on Biological
         Variability
   7.4 Evaluation of Analytical Performance Based on
         Published Professional Recommendations
   7.5 Evaluation of Analytical Performance Based on Goals
         Set by Accrediting Agencies
   7.6 Evaluation of Analytical Performance Based on the
         General Capability
8 Statistical Evaluation of Comparability Data
   8.1 Hypothesis Testing
   8.2 Statistical Analysis of Comparability Data
   8.3 Fixed Limit Evaluation
9 Point-of-Care Testing (POCT)
   9.1 Specimen Selection
   9.2 Specimen Acquisition
   9.3 Range of Specimen Values
   9.4 Multiple Devices of the Same Make and Model
   9.5 Statistical Considerations for POC Comparability
         Testing
10 Range Test Comparability Protocol
   10.1 Select an Analyte for Comparison
   10.2 Select the Instruments to Be Compared
   10.3 Identify an Approximate Analyte Concentration for
         Comparison Testing
   10.4 Calculate the Desired Concentration or Activity to
          Be Used for Comparison Sample Selection
   10.5 Select a Sample for Comparison Testing
   10.6 Select the Appropriate Level of Acceptance Criteria
         That Can Be Applied to the Comparison Test (from
         Section 7)
   10.7 Set the Critical Difference for the Comparability
         Test at the Recommended Total Error or Bias Limit
         Determined in Section 10.6
   10.8 Determine the Number of Replicates to Be Run
   10.9 Perform the Comparison
   10.10 Evaluate the Clinical Relevance of the Comparison
         Results
   10.11 Troubleshooting Noncomparability
References
Appendix A - Worked Examples
Appendix B - Table of Critical Differences (%) for the Range Test
Appendix C - Statistical Concepts
Appendix D - Biological Variation
Summary of Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI Reference Materials

Specifies guidelines for performing the PT and APTT tests in the clinical laboratory, for reporting results, and for identifying sources of error.

DevelopmentNote
Supersedes NCCLS H47 A. (06/2008)
DocumentType
Miscellaneous Product
PublisherName
Clinical Laboratory Standards Institute
Status
Superseded
SupersededBy
Supersedes

CLSI H48 : 2ED 2016 DETERMINATION OF COAGULATION FACTOR ACTIVITIES USING THE ONE-STAGE CLOTTING ASSAY
CLSI H60 A : 1ED 2014 LABORATORY TESTING FOR THE LUPUS ANTICOAGULANT

CLSI C37 A : 1ED 99 PREPARATION AND VALIDATION OF COMMUTABLE FROZEN HUMAN SERUM POOLS AS SECONDARY REFERENCE MATERIALS FOR CHOLESTEROL MEASUREMENT PROCEDURES
CLSI EP5 A2 : 2ED 2004 EVALUATION OF PRECISION PERFORMANCE OF QUANTITATIVE MEASUREMENT METHODS
CLSI M29 A3 : 3ED 2005 ACQUIRED INFECTIONS; APPROVED GUIDELINE
CLSI EP15 A2 : 2ED 2006 USER VERIFICATION OF PERFORMANCE FOR PRECISION AND TRUENESS
CLSI EP32 R : 1ED 2006 METROLOGICAL TRACEABILITY AND ITS IMPLEMENTATION
CLSI C30 A2 : 2ED 2002 POINT-OF-CARE BLOOD GLUCOSE TESTING IN ACUTE AND CHRONIC CARE FACILITIES
CLSI C24 A3 : 3ED 2006 STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS
CLSI EP9 A2 : 2ED 2002 METHOD COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.